Ironwood Pharmaceuticals (IRWD) Competitors $1.41 -0.05 (-3.42%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$1.45 +0.04 (+2.84%) As of 03/28/2025 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IRWD vs. MYGN, ZBIO, RIGL, EBS, VSTM, VNDA, CDXS, XOMA, SGMO, and ACHVShould you be buying Ironwood Pharmaceuticals stock or one of its competitors? The main competitors of Ironwood Pharmaceuticals include Myriad Genetics (MYGN), Zenas Biopharma (ZBIO), Rigel Pharmaceuticals (RIGL), Emergent BioSolutions (EBS), Verastem (VSTM), Vanda Pharmaceuticals (VNDA), Codexis (CDXS), XOMA (XOMA), Sangamo Therapeutics (SGMO), and Achieve Life Sciences (ACHV). These companies are all part of the "biotechnology" industry. Ironwood Pharmaceuticals vs. Myriad Genetics Zenas Biopharma Rigel Pharmaceuticals Emergent BioSolutions Verastem Vanda Pharmaceuticals Codexis XOMA Sangamo Therapeutics Achieve Life Sciences Ironwood Pharmaceuticals (NASDAQ:IRWD) and Myriad Genetics (NASDAQ:MYGN) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, community ranking, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends. Which has more volatility and risk, IRWD or MYGN? Ironwood Pharmaceuticals has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500. Comparatively, Myriad Genetics has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500. Is IRWD or MYGN more profitable? Ironwood Pharmaceuticals has a net margin of -0.65% compared to Myriad Genetics' net margin of -14.09%. Ironwood Pharmaceuticals' return on equity of -0.96% beat Myriad Genetics' return on equity.Company Net Margins Return on Equity Return on Assets Ironwood Pharmaceuticals-0.65% -0.96% 0.74% Myriad Genetics -14.09%-4.51%-3.07% Which has higher valuation and earnings, IRWD or MYGN? Myriad Genetics has higher revenue and earnings than Ironwood Pharmaceuticals. Ironwood Pharmaceuticals is trading at a lower price-to-earnings ratio than Myriad Genetics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIronwood Pharmaceuticals$351.41M0.64-$1.00B-$0.03-47.00Myriad Genetics$837.60M0.97-$263.30M-$1.41-6.30 Do institutionals and insiders hold more shares of IRWD or MYGN? 99.0% of Myriad Genetics shares are owned by institutional investors. 12.9% of Ironwood Pharmaceuticals shares are owned by company insiders. Comparatively, 2.1% of Myriad Genetics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts prefer IRWD or MYGN? Ironwood Pharmaceuticals currently has a consensus target price of $8.60, indicating a potential upside of 509.93%. Myriad Genetics has a consensus target price of $21.89, indicating a potential upside of 146.54%. Given Ironwood Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts clearly believe Ironwood Pharmaceuticals is more favorable than Myriad Genetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ironwood Pharmaceuticals 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Myriad Genetics 3 Sell rating(s) 6 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.20 Does the MarketBeat Community favor IRWD or MYGN? Ironwood Pharmaceuticals received 38 more outperform votes than Myriad Genetics when rated by MarketBeat users. Likewise, 61.07% of users gave Ironwood Pharmaceuticals an outperform vote while only 52.84% of users gave Myriad Genetics an outperform vote. CompanyUnderperformOutperformIronwood PharmaceuticalsOutperform Votes51361.07% Underperform Votes32738.93% Myriad GeneticsOutperform Votes47552.84% Underperform Votes42447.16% Does the media refer more to IRWD or MYGN? In the previous week, Ironwood Pharmaceuticals had 4 more articles in the media than Myriad Genetics. MarketBeat recorded 12 mentions for Ironwood Pharmaceuticals and 8 mentions for Myriad Genetics. Myriad Genetics' average media sentiment score of 0.99 beat Ironwood Pharmaceuticals' score of -0.05 indicating that Myriad Genetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ironwood Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Myriad Genetics 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive SummaryIronwood Pharmaceuticals beats Myriad Genetics on 10 of the 18 factors compared between the two stocks. Remove Ads Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRWD vs. The Competition Export to ExcelMetricIronwood PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$225.64M$6.91B$5.63B$7.83BDividend YieldN/A2.73%4.57%4.00%P/E Ratio-47.007.1723.3318.67Price / Sales0.64220.47388.4691.01Price / CashN/A65.6738.1634.64Price / Book-0.646.396.894.23Net Income-$1.00B$142.12M$3.20B$247.15M7 Day PerformanceN/A-5.18%-3.02%-2.17%1 Month Performance-12.42%-7.49%1.63%-5.68%1 Year Performance-83.81%-8.78%9.74%-0.67% Ironwood Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRWDIronwood Pharmaceuticals3.7001 of 5 stars$1.41-3.4%$8.60+509.9%-83.8%$233.64M$351.41M-47.00220Short Interest ↑Analyst RevisionMYGNMyriad Genetics4.1296 of 5 stars$9.98-0.3%$21.89+119.4%-58.3%$911.26M$837.60M-7.682,700Analyst UpgradeZBIOZenas BiopharmaN/A$9.31+11.8%$40.00+329.6%N/A$389.15M$5M-2.62N/AGap UpRIGLRigel Pharmaceuticals2.728 of 5 stars$20.54+1.7%$36.80+79.2%+20.8%$366.91M$179.28M146.72160Positive NewsEBSEmergent BioSolutions4.2117 of 5 stars$5.74+0.3%$14.33+149.9%+84.4%$311.62M$1.01B-1.401,600VSTMVerastem3.0948 of 5 stars$6.88+3.5%$13.88+101.7%-47.5%$306.21M$10M-2.1650Short Interest ↑Analyst RevisionGap UpVNDAVanda Pharmaceuticals4.3708 of 5 stars$4.82+1.0%$16.50+242.3%+14.1%$281.08M$198.77M-15.06290Positive NewsCDXSCodexis3.3256 of 5 stars$3.07+20.4%$8.33+171.4%-19.5%$254.31M$59.35M-3.53250Short Interest ↑Gap UpHigh Trading VolumeXOMAXOMA4.5 of 5 stars$20.93+0.2%$72.00+244.0%-15.5%$250.72M$10.22M-6.0110Analyst ForecastPositive NewsSGMOSangamo Therapeutics2.87 of 5 stars$0.87+0.4%$5.17+493.9%+22.4%$181.52M$57.80M-1.16480Gap UpACHVAchieve Life Sciences1.9186 of 5 stars$2.97+5.7%$15.75+430.3%-38.8%$103.01MN/A-2.6320Positive News Remove Ads Related Companies and Tools Related Companies Myriad Genetics Alternatives Zenas Biopharma Alternatives Rigel Pharmaceuticals Alternatives Emergent BioSolutions Alternatives Verastem Alternatives Vanda Pharmaceuticals Alternatives Codexis Alternatives XOMA Alternatives Sangamo Therapeutics Alternatives Achieve Life Sciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRWD) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ironwood Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IRWD Stock Free IRWD Stock Alerts